College of Pharmacy, Shaanxi University of Chinese Medicine, Xi'an, Shaanxi, 712046, China.
College of Pharmacy, Shaanxi University of Chinese Medicine, Xi'an, Shaanxi, 712046, China.
J Pharm Biomed Anal. 2018 Sep 5;158:339-345. doi: 10.1016/j.jpba.2018.06.016. Epub 2018 Jun 18.
In this study, RNA-seq technology was used to study the protective effect of Compound Longmaining (CLMN) decoction on acute myocardial infarction (AMI). The results of RNA-seq showed that the CLMN decoction has a regulatory effect on the 51 differentially expressed genes (DEGs), which were mainly enriched in the 7 pathways revealed by KEGG analysis. In addition, qPCR technology was used to verify the expression of chemokine (C-C motif) ligand 6 (Ccl6), chemokine (C-C motif) receptor 5 (Ccr5), integrin alpha M (Itgam), neutrophil cytosolic factor 1 (Ncf1), and matrix metallopeptidase 9 (Mmp9). Experiment data showed that the qPCR results were consistent with the RNA-seq results. This study demonstrated that CLMN decoction might regulate the expressions of Ccl6, Ccr5, Itgam, Ncf1 and Mmp9, inhibit the chemokine signaling pathway and leukocyte transendothelial migration to play a protective effect on AMI.
在这项研究中,RNA-seq 技术被用于研究复方龙牡汤对急性心肌梗死(AMI)的保护作用。RNA-seq 的结果表明,复方龙牡汤对 51 个差异表达基因(DEGs)具有调节作用,这些基因主要富集在 KEGG 分析揭示的 7 条途径中。此外,qPCR 技术被用于验证趋化因子(C-C 基元)配体 6(Ccl6)、趋化因子(C-C 基元)受体 5(Ccr5)、整合素 alpha M(Itgam)、中性粒细胞胞质因子 1(Ncf1)和基质金属蛋白酶 9(Mmp9)的表达。实验数据表明,qPCR 结果与 RNA-seq 结果一致。这项研究表明,复方龙牡汤可能通过调节 Ccl6、Ccr5、Itgam、Ncf1 和 Mmp9 的表达,抑制趋化因子信号通路和白细胞跨内皮迁移,对 AMI 发挥保护作用。